Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 18, 2020Multiple Sclerosis JournalOpen Access

Progressive multifocal leukoencephalopathy in dimethyl fumarate-treated multiple sclerosis patients

View Full Paper
Ask AI
Bookmark
Share

Authors

AJAllison JordanThe Ohio State University Wexner Medical CenterJYJennifer YangUniversity of California, Los AngelesCFCaitlyn FisherUniversity of Michigan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Jordan et al. (2020) studied this question.

synapsesocial.com/papers/69df0867d85e58e37b7a0db3https://doi.org/10.1177/1352458520949158
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells2011 · 353 citations
  2. 2Role of CD4 + and CD8 + T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome2011 · 135 citations
  3. 3Progressive multifocal leukoencephalopathy after fingolimod treatment2018 · 148 citations